RTI International, 307 Waverley Oaks Rd, Suite 101, Waltham, MA, 02452, USA.
University of Massachusetts Medical School, 55 Lake Ave. North, Worcester, MA, 01655, USA.
Cancer Causes Control. 2019 Oct;30(10):1137-1144. doi: 10.1007/s10552-019-01218-7. Epub 2019 Aug 17.
Given the associations between poverty and poorer outcomes among older adults with cancer, we sought to understand the effects of dual enrollment in Medicare and Medicaid-as a marker of poverty-on self-reported care experiences among seniors diagnosed with cancer.
Retrospective, observational study using cancer registry, Medicare claims, and care experience survey data (Surveillance, Epidemiology, and End Results [SEER]-Consumer Assessment of Healthcare Providers and Systems [CAHPS®]) for a national sample of fee-for-service (FFS) and Medicare Advantage (MA) enrollees aged 65 or older. We included people with one incident primary, malignant cancer diagnosed between 2005 and 2011, surveyed within 2 years after diagnosis (n = 9,800; 995 dual enrollees). Medicare CAHPS measures included 5 global ratings and 3 composite scores.
After adjustment for potential confounders, people with cancer histories who were dually enrolled were significantly more likely to report better experiences than non-duals on 2 measures (Medicare/their health plan: adjusted odds ratio [aOR]: 0.68, 95% confidence interval [CI] 0.53-0.87; prescription drug plan [PDP]: aOR: 0.54, 95% CI 0.40-0.73).
Dual enrollees with cancer reported better experiences than Medicare-only enrollees in terms of their health plan (Medicare FFS or Medicare Advantage) and their PDP. Better ratings among dually enrolled beneficiaries suggest possible divergence between health outcomes and care experiences, warranting additional investigation.
鉴于贫困与老年癌症患者预后较差之间的关联,我们试图了解医疗保险和医疗补助双重参保(作为贫困的标志)对被诊断患有癌症的老年人自我报告的护理体验的影响。
使用癌症登记处、医疗保险索赔和护理体验调查数据(监测、流行病学和最终结果[SEER]-医疗保健提供者和系统消费者评估[CAHPS®])进行回顾性观察性研究,对全国范围内的收费服务(FFS)和医疗保险优势(MA)参保者进行了调查年龄在 65 岁或以上的人。我们纳入了在 2005 年至 2011 年间诊断出患有单一原发性恶性癌症的人,并在诊断后 2 年内接受调查(n=9800;995 名双重参保者)。医疗保险 CAHPS 测量包括 5 项总体评分和 3 项综合评分。
在调整了潜在混杂因素后,与非双重参保者相比,有癌症病史的双重参保者在 2 项指标上更有可能报告更好的体验(医疗保险/他们的健康计划:调整后的优势比[aOR]:0.68,95%置信区间[CI]:0.53-0.87;处方药计划[PDP]:aOR:0.54,95%CI 0.40-0.73)。
患有癌症的双重参保者在其健康计划(医疗保险 FFS 或医疗保险优势)和 PDP 方面报告的体验优于仅参加医疗保险的参保者。双重参保者的评分较高表明健康结果和护理体验之间可能存在差异,需要进一步调查。